Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-11-19 Novak Rodger President Option exercise +33,618 $14.43 $485K 33,618
2019-11-19 Novak Rodger President Sale −33,618 $70.00 $2.4M 0
2019-11-19 Novak Rodger President Option exercise · Stock Option (Right to Buy) −33,618 236,382
2019-07-10 Novak Rodger President Sale −50,000 $50.00 $2.5M 848,007
2019-06-10 Novak Rodger President Sale −50,000 $45.00 $2.3M 898,007
2019-03-04 Novak Rodger President Sale −64,115 $40.24 $2.6M 960,419
2019-03-04 Novak Rodger President Sale −8,912 $41.29 $368K 951,507
2019-03-04 Novak Rodger President Sale −3,500 $42.03 $147K 948,007
2019-03-01 Novak Rodger President Sale −8,693 $40.01 $348K 1,024,534
2019-02-25 Novak Rodger President Sale −14,780 $40.00 $591K 1,033,227
2019-01-09 Novak Rodger President Sale −82,690 $35.01 $2.9M 1,048,007
2019-01-08 Novak Rodger President Sale −17,310 $35.09 $607K 1,130,697
2018-05-17 Novak Rodger President Option exercise +35,240 $1.81 $64K 1,183,247
2018-05-17 Novak Rodger President Option exercise +39,760 $14.00 $557K 1,223,007
2018-05-17 Novak Rodger President Sale −75,000 $60.00 $4.5M 1,148,007
2018-05-17 Novak Rodger President Option exercise · Stock Option (Right to Buy) −35,240 5,586
2018-05-17 Novak Rodger President Option exercise · Stock Option (Right to Buy) −39,760 160,240
2017-09-05 Novak Rodger Chief Executive Officer Option exercise +3,853 $1.81 $7K 1,151,860
2017-09-05 Novak Rodger Chief Executive Officer Sale −3,853 $20.33 $78K 1,148,007
2017-09-05 Novak Rodger Chief Executive Officer Option exercise · Stock Options (Right to Buy) −3,853 40,826

Page 3 of 4 · 67 trades